Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 24)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783030805456, 9783030805463

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Predictive Biomarkers of Immunotherapy Efficacy in RCC and Their Role in Non-metastatic Stages

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_17 ◽

2022 ◽

pp. 221-227

Author(s):

Jasnoor Malhotra ◽

Luis Meza ◽

Nicholas Salgia ◽

Sumanta Kumar Pal

Keyword(s):

Predictive Biomarkers

Download Full-text

Preoperative Immunotherapy for Prostate Cancer: From Bench to Bedside

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_11 ◽

2022 ◽

pp. 133-143

Author(s):

Charles G. Drake

Keyword(s):

Prostate Cancer

Download Full-text

State-of-the-Art and Future Role of Molecular Biomarkers for Patient Selection

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_8 ◽

2022 ◽

pp. 91-107

Author(s):

Tuomas Jalanko ◽

Mathieu Roumiguie ◽

Peter Black

Keyword(s):

Patient Selection ◽

State Of The Art ◽

Molecular Biomarkers ◽

Future Role

Download Full-text

Clinical Case Debate: Neoadjuvant Checkpoint Inhibition Versus Standard Chemotherapy

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_2 ◽

2022 ◽

pp. 13-25

Author(s):

Marco Bandini ◽

Giuseppe Basile ◽

Andrea Gallina

Keyword(s):

Clinical Case ◽

Checkpoint Inhibition ◽

Standard Chemotherapy

Download Full-text

The Future of Artificial Intelligence Applied to Immunotherapy Trials

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_20 ◽

2022 ◽

pp. 265-284

Author(s):

Zuhir Bodalal ◽

Stefano Trebeschi ◽

Ivar Wamelink ◽

Kevin Groot Lipman ◽

Teresa Bucho ◽

...

Keyword(s):

Artificial Intelligence ◽

The Future

Download Full-text

The Role of Immunotherapy as Bladder-Sparing Solution for Muscle-Invasive and Non-muscle-Invasive Bladder Cancer: Current Status and Future Perspectives

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_9 ◽

2022 ◽

pp. 109-122

Author(s):

Giuseppe Basile ◽

Giovanni Enrico Cacciamani ◽

Simone Scuderi ◽

Francesco Barletta ◽

Vito Cucchiara ◽

...

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Current Status ◽

Future Perspectives ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Bladder Sparing

Download Full-text

Ongoing Trial and Clinical Trial Endpoint Debate: The Role of Pathologic Response as a Surrogate of Survival Endpoints

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_7 ◽

2022 ◽

pp. 75-89

Author(s):

Praful Ravi ◽

Guru P. Sonpavde

Keyword(s):

Clinical Trial ◽

Pathologic Response ◽

Ongoing Trial ◽

Survival Endpoints ◽

Clinical Trial Endpoint ◽

Trial Endpoint

Download Full-text

The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Renal Cell Carcinoma

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_23 ◽

2022 ◽

pp. 299-302

Author(s):

Alberto Martini ◽

Alessandro Larcher

Keyword(s):

Artificial Intelligence ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

The Future

Download Full-text

Clinical Cases Debate: Neoadjuvant Versus Adjuvant Immunotherapy in Localized Renal Cell Carcinoma (RCC)

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_15 ◽

2022 ◽

pp. 187-205

Author(s):

William Paul Skelton ◽

Aaron Dahmen ◽

Monica Chatwal ◽

Rohit K. Jain ◽

Jad Chahoud ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Adjuvant Immunotherapy ◽

Localized Renal Cell Carcinoma ◽

Clinical Cases

Download Full-text

Background: State-of-the-Art and Ongoing Developments

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers ◽

10.1007/978-3-030-80546-3_1 ◽

2022 ◽

pp. 3-11

Author(s):

Marco Moschini ◽

Laura Marandino ◽

Francesco Montorsi

Keyword(s):

State Of The Art ◽

Background State

Download Full-text

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary CancersLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Predictive Biomarkers of Immunotherapy Efficacy in RCC and Their Role in Non-metastatic Stages

Preoperative Immunotherapy for Prostate Cancer: From Bench to Bedside

State-of-the-Art and Future Role of Molecular Biomarkers for Patient Selection

Clinical Case Debate: Neoadjuvant Checkpoint Inhibition Versus Standard Chemotherapy

The Future of Artificial Intelligence Applied to Immunotherapy Trials

The Role of Immunotherapy as Bladder-Sparing Solution for Muscle-Invasive and Non-muscle-Invasive Bladder Cancer: Current Status and Future Perspectives

Ongoing Trial and Clinical Trial Endpoint Debate: The Role of Pathologic Response as a Surrogate of Survival Endpoints

The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Renal Cell Carcinoma

Clinical Cases Debate: Neoadjuvant Versus Adjuvant Immunotherapy in Localized Renal Cell Carcinoma (RCC)

Background: State-of-the-Art and Ongoing Developments

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers
Latest Publications